Search Results - "Ioffe, Olga B."

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199 by Sherman, Mark E, Piedmonte, Marion, Mai, Phuong L, Ioffe, Olga B, Ronnett, Brigitte M, Van Le, Linda, Ivanov, Iouri, Bell, Maria C, Blank, Stephanie V, DiSilvestro, Paul, Hamilton, Chad A, Tewari, Krishnansu S, Wakeley, Katie, Kauff, Noah D, Yamada, S Diane, Rodriguez, Gustavo, Skates, Steven J, Alberts, David S, Walker, Joan L, Minasian, Lori, Lu, Karen, Greene, Mark H

“…Risk-reducing salpingo-oophorectomy (RRSO) lowers mortality from ovarian/tubal and breast cancers among BRCA1/2 mutation carriers. Uncertainties persist…”
Get full text

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer by Berg, Wendie A, Gutierrez, Lorena, NessAiver, Moriel S, Carter, W Bradford, Bhargavan, Mythreyi, Lewis, Rebecca S, Ioffe, Olga B

“…To prospectively assess accuracy of mammography, clinical examination, ultrasonography (US), and magnetic resonance (MR) imaging in preoperative assessment of…”
Get more information

Absolute Risk of Endometrial Carcinoma During 20-Year Follow-Up Among Women With Endometrial Hyperplasia by LACEY, James V, SHERMAN, Mark E, RUSH, Brenda B, RONNETT, Brigitte M, IOFFE, Olga B, DUGGAN, Máire A, GLASS, Andrew G, RICHESSON, Douglas A, CHATTERJEE, Nilanjan, LANGHOLZ, Bryan

“…PURPOSE The severity of endometrial hyperplasia (EH)-simple (SH), complex (CH), or atypical (AH)-influences clinical management, but valid estimates of…”
Get full text

Targeting abnormal DNA repair in therapy-resistant breast cancers by Tobin, Lisa A, Robert, Carine, Nagaria, Pratik, Chumsri, Saranya, Twaddell, William, Ioffe, Olga B, Greco, George E, Brodie, Angela H, Tomkinson, Alan E, Rassool, Feyruz V

“…Although hereditary breast cancers have defects in the DNA damage response that result in genomic instability, DNA repair abnormalities in sporadic breast…”
Get full text

Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study by Devor, Eric J., Miecznikowski, Jeffrey, Schickling, Brandon M., Gonzalez-Bosquet, Jesus, Lankes, Heather A., Thaker, Premal, Argenta, Peter A., Pearl, Michael L., Zweizig, Susan L., Mannel, Robert S., Brown, Amy, Ramirez, Nilsa C., Ioffe, Olga B., Park, Kay J., Creasman, William T., Birrer, Michael J., Mutch, David, Leslie, Kimberly K.

“…•This study screened for miRNAs associated with endometrial cancer recurrence.•We profiled miRNAs from the three major endometrial cancer subtypes in…”
Get full text

Cystic lesions of the breast: sonographic-pathologic correlation by Berg, Wendie A, Campassi, Cristina I, Ioffe, Olga B

“…To understand the pathologic basis for sonographic features of cystic lesions of the breast and determine appropriate assessment and management recommendations…”
Get more information

Metastasizing pleomorphic adenoma of the salivary gland by Manucha, Varsha, Ioffe, Olga B

“…Metastasizing pleomorphic adenoma of salivary glands is a group of rare tumors that are histologically identical to benign mixed tumors and that inexplicably…”
Get full text

Breast carcinoma: Is molecular evaluation a necessary part of current pathological analysis? by Koka, Rima, MD, PhD, Ioffe, Olga B., MD

“…Abstract Breast cancer is the most common women cancer and is the second leading cause of cancer-related mortality in women. While the last two decades…”
Get full text

Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities by Ma, Xinrong, Kundu, Namita, Ioffe, Olga B, Goloubeva, Olga, Konger, Raymond, Baquet, Claudia, Gimotty, Phyllis, Reader, Jocelyn, Fulton, Amy M

“…Cyclooxygenase-2 is frequently overexpressed and associated with poor prognosis in breast cancer. The cyclooxygenase-2 product prostaglandin E(2) elicits…”
Get full text

α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration by Boggs, Amanda E, Vitolo, Michele I, Whipple, Rebecca A, Charpentier, Monica S, Goloubeva, Olga G, Ioffe, Olga B, Tuttle, Kimberly C, Slovic, Jana, Lu, Yiling, Mills, Gordon B, Martin, Stuart S

“…Metastatic cases of breast cancer pose the primary challenge in clinical management of this disease, demanding the identification of effective therapeutic…”
Get full text

PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma by Varki, Vinod, Ioffe, Olga B., Bentzen, Soren M., Heath, Jon, Cellini, Ashley, Feliciano, Josephine, Zandberg, Dan P.

“…Background To characterize the expression of co-signaling molecules PD-L1, PD-1, and B7-H3 in cutaneous squamous cell carcinoma (cSCC) by immune status…”
Get full text

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis by Terunuma, Atsushi, Putluri, Nagireddy, Mishra, Prachi, Mathé, Ewy A, Dorsey, Tiffany H, Yi, Ming, Wallace, Tiffany A, Issaq, Haleem J, Zhou, Ming, Killian, J Keith, Stevenson, Holly S, Karoly, Edward D, Chan, King, Samanta, Susmita, Prieto, DaRue, Hsu, Tiffany Y T, Kurley, Sarah J, Putluri, Vasanta, Sonavane, Rajni, Edelman, Daniel C, Wulff, Jacob, Starks, Adrienne M, Yang, Yinmeng, Kittles, Rick A, Yfantis, Harry G, Lee, Dong H, Ioffe, Olga B, Schiff, Rachel, Stephens, Robert M, Meltzer, Paul S, Veenstra, Timothy D, Westbrook, Thomas F, Sreekumar, Arun, Ambs, Stefan

“…Metabolic profiling of cancer cells has recently been established as a promising tool for the development of therapies and identification of cancer biomarkers…”
Get full text

Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial by Powell, Matthew A, Filiaci, Virginia L, Hensley, Martee L, Huang, Helen Q, Moore, Kathleen N, Tewari, Krishnansu S, Copeland, Larry J, Secord, Angeles A, Mutch, David G, Santin, Alessandro, Warshal, David P, Spirtos, Nick M, DiSilvestro, Paul A, Ioffe, Olga B, Miller, David S

“…This phase III randomized trial (NCT00954174) tested the null hypothesis that paclitaxel and carboplatin (PC) is inferior to paclitaxel and ifosfamide (PI) for…”
Get full text

Measurement of Sex Steroid Hormones in Breast Adipocytes: Methods and Implications by FALK, Roni T, GENTZSCHEIN, Elisabet, STANCZYK, Frank Z, BRINTON, Louise A, GARCIA-CLOSAS, Montserrat, IOFFE, Olga B, SHERMAN, Mark E

“…Background: The lack of validated methods for measuring sex steroid hormones in breast tissue has limited our knowledge of their role in the development of…”
Get full text

Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy by Berg, W A, Mrose, H E, Ioffe, O B

“…To review outcomes of lesions diagnosed at core-needle breast biopsy as atypical lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS). Results from…”
Get more information

Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors by Nikitakis, Nikolaos G, Tosios, Konstantinos I, Papanikolaou, Vasileios S, Rivera, Helen, Papanicolaou, Stavros I, Ioffe, Olga B

“…On the basis of the heterogeneity of cytokeratins 7 and 20 expression in malignant epithelial tumors, the cytokeratin 7/20 immunophenotype has served as a…”
Get full text

Epithelial-to-Mesenchymal Transition Promotes Tubulin Detyrosination and Microtentacles that Enhance Endothelial Engagement by WHIPPLE, Rebecca A, MATRONE, Michael A, CHO, Edward H, BALZER, Eric M, VITOLO, Michele I, YOON, Jennifer R, IOFFE, Olga B, TUTTLE, Kimberly C, JING YANG, MARTIN, Stuart S

“…Epithelial-to-mesenchymal transition (EMT) is associated with increased breast tumor metastasis; however, the specific mechanisms by which EMT promotes…”
Get full text

Human muscle stem cells are refractory to aging by Novak, James S., Mázala, Davi A. G., Nearing, Marie, Hindupur, Ravi, Uapinyoying, Prech, Habib, Nayab F., Dickson, Tessa, Ioffe, Olga B., Harris, Brent T., Fidelia‐Lambert, Marie N., Rossi, Christopher T., Hill, D. Ashely, Wagner, Kathryn R., Hoffman, Eric P., Partridge, Terence A.

“…Age‐related loss of muscle mass and strength is widely attributed to limitation in the capacity of muscle resident satellite cells to perform their myogenic…”
Get full text

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus by Wolfson, Aaron H, Brady, Mark F, Rocereto, Thomas, Mannel, Robert S, Lee, Yi-Chun, Futoran, Robert J, Cohn, David E, Ioffe, Olga B

“…Abstract Purpose After initial surgery, there has been no established consensus regarding adjunctive therapy for patients with uterine carcinosarcoma (CS)…”
Get full text

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence by Brasky, Theodore M, Felix, Ashley S, Cohn, David E, McMeekin, D Scott, Mutch, David G, Creasman, William T, Thaker, Premal H, Walker, Joan L, Moore, Richard G, Lele, Shashikant B, Guntupalli, Saketh R, Downs, Levi S, Nagel, Christa I, Boggess, John F, Pearl, Michael L, Ioffe, Olga B, Park, Kay J, Ali, Shamshad, Brinton, Louise A

“…Recent data suggest that the use of nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with reductions in endometrial cancer risk, yet very few…”
Get full text